Cargando…
PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab
Autores principales: | Vilella, Mireia, Bosque, Montserrat, Trujillo, Juan, Domingo, Xavier, Guijarro, Elisabet, Asensio, Òscar, Valdesoiro, Laura, Larramona, Helena, Maestro, Alba, Domingo, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081866/ http://dx.doi.org/10.1186/2045-7022-4-S1-P49 |
Ejemplares similares
-
PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?
por: Trujillo, Juan Enrique, et al.
Publicado: (2014) -
Nasal and Exhaled Nitric Oxide in Allergic Rhinitis
por: Lee, Keon Jung, et al.
Publicado: (2012) -
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma
por: Brooks, Elizabeth A, et al.
Publicado: (2019) -
PD11 - Omalizumab in children: experience in the Immunoallergology Department
por: Aguiar, Rita, et al.
Publicado: (2014) -
Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD
por: Gao, Jie, et al.
Publicado: (2017)